TL;DR
- •IOC consensus reviews report symptoms of depression and anxiety in roughly 1 in 3 elite athletes — comparable to or higher than age-matched general-population rates, with injured and retiring athletes at substantially elevated risk.
- •Performance anxiety, injury-related depression, body-image pressure, and the abrupt identity loss at retirement create a stressor profile that's distinct from general-population presentations.
- •Ketamine is NOT on the WADA Prohibited List for in-competition or out-of-competition use as of 2026 — but each league and governing body has its own policy, and a Therapeutic Use Exemption (TUE) consultation is appropriate before starting if you compete under any sanctioning body.
- •Telehealth ketamine therapy fits the athlete schedule — sessions on rest days or off-season, no clinic visits during training blocks, completely private from team physicians and league systems if desired.
- •Tovani is direct-pay ($349/month, HSA/FSA eligible) — bypasses team-insurance or league-health records that some athletes prefer to keep separate.
- •Most athlete-patients say what mattered most was: scheduling around training and competition; understanding the WADA/league nuance; same physician every visit; complete control over what their team's medical staff knows.
The stressors specific to your work
- •Performance anxiety with measurable, public outcomes every game or competition
- •Injury-driven depression — physical limits compound identity loss
- •Retirement transition — sudden identity dissolution after a career organized around sport
- •Body-image and weight-management pressures specific to position or discipline
- •Career impermanence — multi-year peak windows with no obvious second act
- •Team-environment masculinity norms that suppress help-seeking
Why telehealth works for athletes
- •No clinic visits — fits between training sessions, travel, and competition
- •Sessions scheduled on rest days or during off-season
- •Treatment in your own home — separate from team facilities and medical staff
- •Same physician every visit — relationship continuity across a long season
- •Complete control over whether team medical staff is informed (your choice)
Privacy considerations
- •Tovani is direct-pay — no insurance claim filed unless you submit for reimbursement yourself.
- •Patient records are private and NEVER shared with teams, leagues, sanctioning bodies, agents, or sponsors without your explicit written authorization.
- •WADA does not list ketamine as a prohibited substance for in-competition or out-of-competition use as of the 2026 Prohibited List, but verify against your specific league's policy (NCAA, NFL, NBA, MLB, NHL, MLS, USOPC each have their own rules — many follow WADA, but not all).
- •For competitive athletes, a Therapeutic Use Exemption (TUE) consultation with your governing body before starting is appropriate; your Tovani physician can provide documentation for that process.
5-minute screening · Reviewed by a board-certified physician · FL & NJ · $349/month
Frequently asked
Will a ketamine prescription disqualify me under WADA or my league's rules?
As of the 2026 WADA Prohibited List, ketamine is NOT listed as a prohibited substance in-competition or out-of-competition. However, leagues vary — NCAA, MLB, NFL, NBA, NHL, MLS, and the USOPC each have their own banned-substance lists, most aligned with WADA but with some additions. Before starting treatment, check your specific governing body's rules. A Therapeutic Use Exemption (TUE) consultation is the appropriate path if you have any uncertainty; your Tovani physician can provide documentation.
I'm dealing with depression after a season-ending injury. Is this normal?
Yes — injury-related depression is well-documented in sports-psychology literature, with up to 50% of injured elite athletes meeting depression criteria during rehab. The combination of physical loss, identity disruption, isolation from team, and uncertain return-to-play creates a high-risk window. Standard interventions (sports psychology, gradual return-to-activity, SSRIs) work for many; for treatment-resistant cases, ketamine's rapid mechanism can produce noticeable change within days rather than the 4-6 weeks SSRIs typically require.
How do I do this without my team finding out?
Tovani is direct-pay (no team-insurance claim), HIPAA-protected (no records shared without your authorization), and telehealth (no team-facility visits). Many athlete-patients keep this entirely separate from team medical staff. Others choose to loop in a team physician — that's your call, not a default. If you compete under a sanctioning body, the TUE process may require some disclosure to a designated medical reviewer, but not to coaches, teammates, agents, or sponsors.
I'm retiring from my sport and feel completely lost. Will ketamine help?
Retirement-transition depression is one of the most documented mental-health risks in elite sport — the identity dissolution can be severe and isn't always responsive to standard SSRIs alone. Ketamine in this context is typically used alongside therapy focused on identity reconstruction and life-after-sport planning. The "neuroplasticity window" effect may enhance therapeutic integration work during this specific transition.
I have performance anxiety that beta-blockers and SSRIs haven't fully solved. What now?
Performance anxiety with somatic features (tremor, voice instability) is often managed with beta-blockers in-competition. For the cognitive and rumination component that beta-blockers don't address, SSRIs and CBT are first-line. When those produce only partial response, options include switching SSRI class, augmentation, or for treatment-resistant cases, ketamine. The choice depends on competition timing, specific symptom pattern, and whether your governing body allows TUEs for the agent in question.
References
- Reardon CL et al. 2019, British Journal of Sports Medicine. IOC consensus statement on mental health in elite athletes — establishes baseline prevalence and the case for sport-specific clinical care including treatment-resistant presentations. PMID 31308063
- Gouttebarge V et al. 2020, British Journal of Sports Medicine. IOC Sport Mental Health Assessment Tool 1 — standardized screening framework for athletes that supports identifying treatment-resistant depression and anxiety appropriate for ketamine consideration. PMID 32948518
- Murrough JW et al. 2013, American Journal of Psychiatry. Ketamine RCT showed 64% response in treatment-resistant depression — relevant for athletes whose depression persists despite SSRIs and standard sports-psychology interventions. PMID 23982301